NICOTINE DISCLOSURE

Eclipse: does it live up to its health claims?

J Slade^1,*, G N Connolly², D Lymperis²

¹ School of Public Health, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
² Massachusetts Department of Public Health, Boston, Massachusetts, USA

Correspondence to:
Correspondence to:
Gregory N Connolly, Massachusetts Department of Public Health, 250 Washington Street, Boston, MA 02108-4619, USA;
greg.connolly{at}state.ma.us

Objective: To examine the plausibility of health claims for Eclipse, a novel smoking article being marketed by the RJ Reynolds Tobacco Company (RJR) as potentially reducing the risk of cancer and other diseases compared to conventional cigarettes.

Data sources: A company product website (www.eclipse.rjrt.com) summarising scientific studies of various versions of Eclipse, and the published review of these studies by an expert panel convened by RJR, an independent study comparing the smoke yields of major carcinogens from Eclipse and two low yield "ultralight" brands (Now and Carlton), and an analysis of the levels of these compounds in Eclipse and Premier (its predecessor) over time.

Analysis: The overall doses and effects of toxins in the aerosol from Eclipse are smaller than those from most conventional cigarettes on a per mg basis. However, two tests that compared Eclipse on a per cigarette basis revealed that Eclipse was as or more toxic than an ultralight cigarette. Studies show that consumers smoke Eclipse (like they do cigarettes) at puff volumes and puff frequencies far higher than those used for the Federal Trade Commission (FTC) test. RJR's test results, which are based on aerosols generated under FTC conditions, may not reflect actual human dosing, since the operating temperature of Eclipse is highly dependent on these puffing parameters. Even under FTC/International Organization for Standardization (ISO) standard measures, Eclipse smoke carcinogen yields were higher than Now, but similar to Carlton. The yields of carcinogens from Premier and different versions of Eclipse have increased over time. Furthermore, the human studies reviewed by the RJR expert panel do not offer compelling evidence of reduced harm, as they have not been conducted in smokers who have adopted Eclipse.

Conclusion: There is as yet unsatisfactory evidence that Eclipse is less harmful than conventional cigarettes. Eclipse appears to be at least as toxic as some commercially available cigarette brands. Consumers may be misled by RJR's health claims into believing that Eclipse is a safer alternative to conventional cigarettes, underscoring the need for regulatory intervention.

Keywords: Eclipse

Abbreviations: FTC, Federal Trade Commission; ISO, International Organization for Standardization; MDPH, Massachusetts Department of Public Health; PREPs, potential reduced exposure products; RJR, RJ Reynolds; SCE, sister chromatid exchange; TPM, total particulate matter

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wayne, G F., Connolly, G N (2009). Regulatory assessment of brand changes in the commercial tobacco product market. Tobacco Control 18: 302-309 [Abstract] [Full Text]  
• Biener, L., Bogen, K., Connolly, G. (2007). Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products. Tobacco Control 16: 306-311 [Abstract] [Full Text]  
• Henningfield, J. E, Rose, C. A, Zeller, M. (2006). Tobacco industry litigation position on addiction: continued dependence on past views. Tobacco Control 15: iv27-iv36 [Abstract] [Full Text]  
• Wayne, G. F. (2006). Potential reduced exposure products (PREPs) in industry trial testimony. Tobacco Control 15: iv90-iv97 [Abstract] [Full Text]  
• Pollay, R W, Dewhirst, T (2003). A Premiere example of the illusion of harm reduction cigarettes in the 1990s. Tobacco Control 12: 322-332 [Abstract] [Full Text]  
• Swauger, J E, Connolly, G N (2003). Eclipse: does it live up to its health claims? * Author's reply. Tobacco Control 12: 104-105 [Full Text]  
• Koh, H K (2002). Accomplishments of the Massachusetts Tobacco Control Program. Tobacco Control 11: ii1-3 [Full Text]